Picture of Vogo SA logo

ALVGO Vogo SA News Story

0.000.00%
fr flag iconLast trade - 00:00
TechnologySpeculativeMicro CapSucker Stock

Brief: Vogo To Develop Saliva-Based Screening Test In Response To COVID-19

April 14 (Reuters) - VOGO SAS  ALVGO.PA :
    * COVID-19 - VOGO PARTICIPATION IN DEVELOPMENT, PRODUCTION
AND
DISTRIBUTION OF A RAPID SALIVA-BASED SCREENING TEST
    * ANNOUNCES THAT IT IS COLLABORATING WITH SCIENTISTS FROM
CNRS
(FRENCH NATIONAL CENTER FOR SCIENTIFIC RESEARCH) LABORATORY
SYS2DIAG, AND WITH BIOTECHNOLOGY COMPANY SKILLCELL FOR PROVIDING
RAPID SALIVA-BASED SCREENING TEST, IF RESULTS OF THE CLINICAL
TRIAL ARE CONCLUSIVE
    * VOGO HAS ALREADY BEGUN DEVELOPING THE TECHNOLOGICAL TOOL
(A
SMARTPHONE APP) THAT WILL PROVIDE THIS AUTOMATION

Source text: https://bit.ly/3cdu30E
Further company coverage:  ALVGO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Vogo SA

See all news